Sanofi Enjaymo gets USFDA okay for cold agglutinin disease Ruchika Sharma8 Feb 2022 11:43 AM ISTThe US list price, or wholesale acquisition cost, of Enjaymo is $1,800 per vial.
Sanofi unveils new corporate brand, logo Ruchika Sharma5 Feb 2022 2:27 PM ISTParis: Sanofi has unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December...
Sanofi, Regeneron get CHMP recommendation for Dupixent approval to treat severe asthma with type 2 inflammation in kids Ruchika Sharma1 Feb 2022 10:00 AM ISTParis: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Medicines Agency's Committee for Medicinal Products for Human...
Sanofi India Managing Director Rajaram Narayanan resigns Ruchika Sharma14 Jan 2022 12:11 PM ISTMumbai: Sanofi India Limited has announced that its Board of Directors have accepted the resignation of its Managing Director, Rajaram Narayanan,...
Lilly Partners with Canadian Pharma Company for therapies for multiple neurologic conditions Medical Dialogues Bureau9 Jan 2022 1:45 PM ISTNDIANAPOLIS - Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research and collaboration agreement with Entos Pharmaceuticals in Canada....
Sanofi partners with AI firm Exscientia to develop up to 15 new drugs Medical Dialogues Bureau8 Jan 2022 3:00 PM ISTNew Delhi: French drugmaker Sanofi SA (SASY.PA) will partner with British AI firm Exscientia Plc (EXAI.O) to develop up to 15 drug candidates across...
French court backs class action against Sanofi over Depakine drug Medical Dialogues Bureau6 Jan 2022 11:52 AM ISTPARIS: A French court ruled on Wednesday that families of victims of Depakine, an epilepsy drug that caused birth defects and learning difficulties...
Lawsuit accusing Sanofi, Eli Lilly of scheming to inflate drugs' prices pared down Ruchika Sharma20 Dec 2021 2:33 PM ISTNew Delhi: A federal judge on Friday pared down a class action lawsuit brought by consumers accusing three of the biggest makers of diabetes drugs,...
Sanofi to acquire Origimm Biotechnology Ruchika Sharma1 Dec 2021 11:30 AM ISTParis: Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH, an Austrian privately owned biotechnology company...
Sanofi wins second chemotherapy drug Taxotere bellwether trial verdict Medical Dialogues Bureau22 Nov 2021 12:00 PM ISTNew Delhi: Sanofi provided sufficient warning to a Louisiana woman that its chemotherapy drug Taxotere could cause permanent hair loss, a jury found...
Sanofi invests USD 180 million equity in Owkin to advance oncology pipeline Ruchika Sharma22 Nov 2021 10:00 AM ISTParis: Sanofi has announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development...
Sanofi to invest up to Rs 445 crore in Gyroscope Therapeutics Ruchika Sharma10 Nov 2021 11:30 AM ISTLondon: Gyroscope Therapeutics Holdings plc has recently announced that Sanofi, a global biopharmaceutical company, has committed to invest up to...
